News By Tag
News By Place
Follow on Google News
Bedfont Scientific Ltd. announces ODM deal with large medical supplier in China
Medical device manufacturer, Bedfont, signs an ODM deal to supply Kangdu with its NObreath FeNO monitor
By: Bedfont Scientific Ltd
FeNO is a biomarker for airway inflammation, helping in the control and diagnosis of asthma and also the differentiation between asthma and other respiratory diseases. Measuring FeNO through breath analysis, making the process quick, simple and non-invasive for both the GP and the patient. Interpreting FeNO levels aids in identifying patients who do/do not require on-going treatment whilst also differentiating between allergic (eosinophilic)
The ODM agreement for NObreath® means Bedfont designs and manufactures the monitor and Kangdu distributes the product under their branding, EZbreath.
Mr. Zhu Chun Ming, Managing Director at Kangu, commented, "Bedfont's NObreath® is a very innovative and patient-friendly device; we are excited to integrate this monitor into our existing range of high-quality respiratory medical devices and help Bedfont expand its reach through the medical market in China."
Jason Smith, Managing Director at Bedfont, adds, "We are looking forward to working with Kangdu to help improve asthma diagnosis and management in China. This new strategic partnership is a huge step for Bedfont as it will enable us to access this new market and help us to further highlight FeNO breath testing and its benefits."
Bedfont Scientific Ltd